Cortexa Biopharma
Marcus Thorne · Head of CMC KB v1Deal stage
— where this deal is in its journey, first contact to closeDeal snapshot
Win chance, the value at stake, and how far this deal has come.
Win chance
Weighted to $130K
Value at stake
Full value vs. risk-adjusted.
Pipeline progress
Qualified · 6d since touch
Cortexa Biopharma is in Qualified — $260K open, weighted to $130K at 50% win odds. Recommended next move: Approve the pitch for Cortexa Biopharma.
Recommended: Approve the pitch for Cortexa Biopharma
A quick read on this deal from your agent — where it stands and the smartest next move — so you're prepared before you call or email. The agent never reaches out on its own.
Deal value
$260K
The full amount if it closes.
Weighted
$130K
50% chance of closing
Owner
Suren DheenWho's running this deal — that's you.
Last activity
Your most recent logged call, email, or note — 6 days ago.
Next step scheduled: Jul 26, 2026
Agent — next best action for this deal
Approve the pitch for Cortexa Biopharma
The pitch is written and waiting on your compliance sign-off — approve it and it can go out, or send it back with a note.
Follow up with Cortexa Biopharma
You set a follow-up with Cortexa Biopharma for 7/26/2026. Draft the recap with a concrete next step so it doesn't slip.
Recommended Services
Position NDA/MAA CMC Writing against Cortexa Biopharma's near-term regulatory milestones.
Single-pane monitoring across FDA, EMA and 120+ agencies.
Activity
- InterestedJul 16, 2026 • 6:00 PM
Keen on CTD/CMC support for the EMA filing.
Follow-up Jul 26, 2026Logged by Suren Dheen